Menaquinone-4 alleviates hypoxic-ischemic brain damage in neonatal rats by reducing mitochondrial dysfunction via Sirt1-PGC-1α-TFAM signaling pathway

Post time 2024-6-17 16:11:11

journal：International Immunopharmacology

Authors：Xiaoli Feng; Yihui Zheng; Niping Mao; Ming Shen; Liuxi Chu; Yu Fang; Mengdan Pang; Zhouguang Wang; Zhenlang Lin

Published date：2024-6-

DOI：10.1016/j.intimp.2024.112257

PDF link：https://www.sciencedirect.com/sc ... 567576924007768/pdf

Article link：http://dx.doi.org/10.1016/j.intimp.2024.112257

Article Source：Elsevier BV。

Remark：

Post time 2024-6-17 16:11:12

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Menaquinone-4 alleviates hypoxic-ischemic brain damage in neonatal rats by reducing mitochondrial dysfunction via Sirt1-PGC-1α-TFAM signaling pathway

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Menaquinone-4 alleviates hypoxic-ischemic brain damage in neonatal rats by reducing mitochondrial dysfunction via Sirt1-PGC-1α-TFAM signaling pathway Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Menaquinone-4 alleviates hypoxic-ischemic brain damage in neonatal rats by reducing mitochondrial dysfunction via Sirt1-PGC-1α-TFAM signaling pathway